No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 1.6x · 10Y median 1.1x · 76th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 23
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T17:51:51.727Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T17:51:51.727Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T17:51:51.727Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T17:51:51.727Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T17:51:51.727Z. Latest historical point 2026-02-25.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T17:51:51.727Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T17:51:51.727Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T17:51:51.727Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for The Honest Company, Inc. (HNST) stock was $5.07 as of Oct 6, 2026, 1:50 PM EDT, down 1.61% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +40.1% · 3-year avg +63.9%/yr · 5-year avg -11.8%/yr
The Honest Company, Inc. offers a wide range of consumer products, encompassing baby necessities such as diapers and wipes, various personal care and beauty items, and household and health-focused goods.
Household & Personal Products · Los Angeles, CA
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2023-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Nov 4, 2026
29 days away
EPS Estimate
0.00
Revenue Est.
$80.79M
Last Quarter Results
EPS
$0.10
vs Estimate
$0.01
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1HNST | $557.77M | $5.07 | -1.61% | +40.10% | -11.82% | N/A | N/A |
| 2HELE | $594.65M | $25.53 | -0.43% | -3.01% | -34.93% | -11.45% | vs HNST |
| 3DNUT | $513.41M | $2.98 | +3.04% | -23.45% | -26.27% | N/A | vs HNST |
| 4MAMA | $606.12M | $13.04 | +1.68% | +20.38% | +41.01% | N/A | vs HNST |
| 5YSWY | $629.87M | $20.20 | +0.68% | N/A | N/A | N/A | vs HNST |
| 6LINC | $711.18M | $22.42 | +0.99% | -2.19% | +26.01% | +26.48% | vs HNST |
forward FY estimate
42.82
$83.30M
vs Estimate
$77.83M
Consensus Rating
Based on 6 analysts
Average Price Target
$5.20
+2.6% upside
Low
$5.00
Current
$5.07
High
$5.70
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.07 | $0.00 | $0.07 | 5 |
| Quarter ending Dec 2026 | $-0.01 | $0.01 | $0.02 | 5 |
| Quarter ending Mar 2027 | $0.03 | $0.03 | $0.03 | 3 |
| Quarter ending Jun 2027 | $0.03 | $0.04 | $0.04 | 3 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $0.11 | $0.12 | $0.12 | 4 |
| FY 2027 | $0.07 | $0.11 | $0.16 | 5 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $79.34M | $80.79M | $82.36M | 5 |
| Quarter ending Dec 2026 | $78.65M | $80.27M | $81.72M | 5 |
| Quarter ending Mar 2027 | $81.27M | $82.86M | $84.50M | 4 |
| Quarter ending Jun 2027 | $85.98M | $87.66M | $89.39M | 4 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Dec 31, 2026, matching Key Metrics.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $322.41M | $322.57M | $322.91M | 6 |
| FY 2027 | $330.85M | $335.96M | $340.50M | 6 |
